Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2011-01-18
2011-01-18
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085600, C514S04400A
Reexamination Certificate
active
07871603
ABSTRACT:
Use of interferon-beta (IFN-β) and/or IFN-λ for treating rhinovirus (RV) infection in elderly people, particularly elderly people who are, or have been long-term smokers, especially those who have a clinical history of recurrent RV infections, and may have other medical conditions, such as cardiac or circulation problems, and who are liable to suffer severe complications/high mortality from poor innate ability to fight such a viral infection.
REFERENCES:
patent: WO-2005/087253 (2005-09-01), None
patent: WO 2005/105136 (2005-10-01), None
patent: WO-2007/029041 (2007-03-01), None
Halme et al (Respiration 61:105-107, 1994).
Halme et al (International Journal of Radiation Oncology Biology Physics 31:930101, 1995).
Cohen et al (American Journal of Public Health 83:1277-11283, 1993).
Gauvreau et al (American Journal of Respiratory and Cricical Care Medicine 174:15-20, 2006).
Rudolph et al (Molecular Therapy 12:493-501, 2005).
McLachlan et al (Molecular Therapy 15:348-354, 2007).
Ank et al., J Virol (2006) 80:4501-4509.
Bensenor et al., AEP (2001) 11:225-231.
Bucchieri et al., “Bronchial Epithelial Cells from Smokers Have a Poor Innate Response to Infection with Rhinovirus,” presentation dated May 24, 2006, publication p. A842 [Poster Board #618].
Carrat et al., Intensive Care Med (2006) 32:156-159.
Cohen et al., Am J Public Health (1993) 83:1277-1283.
Contoli et al., Nat Med (2006) 12:1023-1026.
El-Sahly et al., Clin Infect Dis (2000) 31:96-100.
Falsey et al., J Infect Dis (2002) 185:1338-1341.
Foo et al., “In Vitro Model of Rhinoviral Infection of Primary Bronchial Epithelial Cells from Smokers,” presentation dated May 24, 2006, publication p. A842 [Poster Board #616].
Higgins et al., J Interferon Res (1986) 6:153-159.
Louie et al., Clin Infect Dis (2005) 41:262-265.
Monto et al., J Infect Disease (1987) 156:43.
Pistelli et al., Eur Respir J (2003) 21:10S-14S.
Sperber et al., J Infect Dis (1989) 160:700-705.
Uze and Monneron, Biochimie (2007) 89(6-7):729-734.
Venarske et al., J Infect Dis (2006) 193:1536-1543.
Wark et al., J Exp Med (2005) 201:937-947.
Davies Donna
Foo Soo-Wei
Puddicombe Sarah Margaret
Morrison & Foerster / LLP
Mosher Mary E
Synairgen Research Limited
LandOfFree
Interferon-beta and/or lambda for use in treating rhinovirus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interferon-beta and/or lambda for use in treating rhinovirus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon-beta and/or lambda for use in treating rhinovirus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672798